Obesity: Difference between revisions

Jump to navigation Jump to search

Obesity (view source)

Revision as of 10:05, 18 August 2023

3,868 bytes added ,  1 year ago
no edit summary
No edit summary
No edit summary
Line 16: Line 16:


[https://pubmed.ncbi.nlm.nih.gov/1858735/ Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity]
[https://pubmed.ncbi.nlm.nih.gov/1858735/ Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity]
1. Hannon TS, Arslanian SA. Obesity in Adolescents. New England Journal of Medicine. 2023;389(3):251-261. doi:10.1056/NEJMcp2102062
2. Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016. Jama. 2018;319(16):1723-1725. doi:10.1001/jama.2018.3060
3. Boyland EJ, Nolan S, Kelly B, et al. Advertising as a cue to consume: a systematic review and meta-analysis of the effects of acute exposure to unhealthy food and nonalcoholic beverage advertising on intake in children and adults12. The American Journal of Clinical Nutrition. 2016/02/01/ 2016;103(2):519-533. doi:https://doi.org/10.3945/ajcn.115.120022
4. Hampl SE, Hassink SG, Skinner AC, et al. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. Pediatrics. 2023;151(2)doi:10.1542/peds.2022-060640
5. Inge TH, Courcoulas AP, Jenkins TM, et al. Five-Year Outcomes of Gastric Bypass in Adolescents as Compared with Adults. The New England journal of medicine. May 30 2019;380(22):2136-2145. doi:10.1056/NEJMoa1813909
6. Hampl, S. E., Hassink, S. G., Skinner, A. C., Armstrong, S. C., Barlow, S. E., Bolling, C. F., ... & Okechukwu, K. (2023). Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics, 151(2), e2022060640.
7. Hampl, S. E., Hassink, S. G., Skinner, A. C., Armstrong, S. C., Barlow, S. E., Bolling, C. F., ... & Okechukwu, K. (2023). Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics, 151(2), e2022060640.
8. Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF; STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18;384(11):989-1002. doi: 10.1056/NEJMoa2032183. Epub 2021 Feb 10. PMID: 33567185.
9. American Society of Anesthesiologists. Patients Taking Popular Medications for Diabetes and Weight Loss Should Stop Before Elective Surgery, ASA Suggests. Accessed 07/20/2023, www.asahq.org/about-asa/newsroom/news-releases/2023/06/patients-taking-popular-medications-for-diabetes-and-weight-loss-should-stop-before-elective-surgery
10. Kelly AS, Auerbach P, Barrientos-Perez M, et al. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. The New England journal of medicine. May 28 2020;382(22):2117-2128. doi:10.1056/NEJMoa1916038
11. Weghuber D, Barrett T, Barrientos-Pérez M, et al. Once-Weekly Semaglutide in Adolescents with Obesity. The New England journal of medicine. Dec 15 2022;387(24):2245-2257. doi:10.1056/NEJMoa2208601
12. Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, Lingvay I, McGowan BM, Oral TK, Rosenstock J, Wadden TA, Wharton S, Yokote K, Kushner RF; STEP 1 Study Group. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022 Aug;24(8):1553-1564. doi: 10.1111/dom.14725. Epub 2022 May 19. PMID: 35441470; PMCID: PMC9542252.
13. Burke C.N., Voepel-Lewis T., Wagner D., Lau I., Baldock A., Malviya S, et. al.: A retrospective description of anesthetic medication dosing in overweight and obese children. Paediatric Anaesthesia 2014; 24: pp. 857-862.
14. Diepstraten J., Chidambaran V., Sadhasivam S., Esslinger H.R., Cox S.L., Inge T. H, et. Al.: Propofol clearance in morbidly obese children and adolescents. Clinical Pharmacokinetics 2012; 51: pp. 543-551.
15. Olutoye O.A., Yu X., Govindan K., Tjia I.M., East D.L., Spearman R, et. al.: The effect of obesity on the ED(95) of propofol for loss of consciousness in children and adolescents. Anesthesia and Analgesia 2012; 115: pp. 147-153.
Retrieved from "https://pedsanesthesia.net/wiki/index.php/Special:MobileDiff/3611"

Navigation menu